品牌分类
- 关注表位标记
- Primary Antibodies
- Recombinant Antibodies from Human Patients
- Anti-Allergen Antibodies
- 多标签控制蛋白
- Recombinant Isotype Controls
- 抗过敏原抗体
- 重组F4/80克隆CI:A3-1
- 体内研究用重组抗体
- Recombinant F4/80 Clone CI:A3-1
- Research-Grade Biosimilars
- 关注来自人类患者的重组抗体
- 同型对照
- 重组免疫球蛋白Fc结构域(Ig-Fc结构域)
- 人源性重组抗体
- 研究级生物仿制药
- 其他产品
- 抗病毒抗体
- 重组自由轻链
- Antibodies to Epitope Tags
- Anti-Virus Antibodies
品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
蚂蚁淘在线 / 品牌中心 / Absolute Antibody / absoluteantibody/Ab00449-1.4 Anti-alpha 5 beta 1 Integrin [M200 (Volociximab)]/Ab00449-1.4/ 200 µg
商品描述
Description:Recombinantmonoclonalantibodytoalpha5beta1Integrin.ManufacturedusingAbAb’sRecombinantPlatformwithvariableregions(i.e.specificity)fromthehybridomaM200(Volociximab).ThisantibodywascreatedusingourproprietaryFcSilent™engineeredFcdomaincontainingkeypointmutationsthatabrogatebindingtoFcgammareceptors.
CloneNumber:M200(Volociximab)
UniProtAccessionNumberofTargetProtein:P08648
AlternativeName(s)ofTarget:Fibronectinreceptor;CD49antigen-likefamilymemberE;Integrinalpha-F;VLA-5;CD49e.
PublishedApplication(s):ELISA;FC;IF;Block;IHC
PublishedSpeciesReactivity:Human
Immunogen:Heterodimerica5ß1Fcfusionprotein
Specificity:Theantibodybindstohumanα5β1 integrinwithaKdof0.367nM(determinedbyBiacore),anEC50of0.2nMandanIC50of2.3nM.
ApplicationNotes:Theantibodybindsspecificallytoα5β1 integrin,whichispartofthesuperfamilyofglycoproteintransmembranereceptorsforligandssuchasfibronectin,vitronectin,lamininsandcollagens.Theα5β1 integrinreceptorplaysakeyroleincellularprocessessuchasinflammation,cellproliferation,angiogenesisandtumourmetastasis.Comprisingthevariabledomainoftheoriginalmouseantibody,achimericmouse:humanIgG4versionofthisantibodyhasbeen testedinvivo:Incynomolgusmonkeyswithlaser-inducedchoroidalneovascularization(CNV),inrabbitmodelsandinhumanvolunteers.TheantibodyreachedPhaseIIclinicaltrialswithPDLBiopharmaandBiogen-Idec.
AntibodyFirstPublishedin:
Ramakrishnanetal.Preclinicalevaluationofananti-alpha5beta1integrin antibody asanovelanti-angiogenicagent.JExpTherOncol.2006;5(4):273-86.PMID:17024968Noteonpublication:Describestheroleofα5β1 integrinintheprogressionofangiogenesis,andthegenerationofVolociximab,achimericmonoclonalantibodywhoseinvitroandinvivouseisevaluatedfortherapeuticuse.
Concentration:Seeviallabel.
Importantnote–Thisproductisforresearchuseonly.Itisnotintendedforuseintherapeuticordiagnosticproceduresforhumansoranimals. Absolute Antibody我们现在与Digital Proteomics合作提供多克隆永生化服务。这意味着您可以生产可复制且不受限制的多克隆试剂,或者利用天然免疫系统来识别新的抗体候选物。对于这项服务,您可以提供免疫宿主生物的血清和B细胞,纯化的抗原用于免疫,或者只是告诉我们您的靶标,我们将做剩下的事情。鉴于其中之一,我们可以提供多达10条由发现引擎选择的重链序列和10条轻链序列,在交互式报告中提供具有蛋白质组学证据的扩展库,根据要求将抗体工程化为任何种类和同种型,以及我们提供的抗体表征数据获得。此服务是100%免版税的。 NOTFORTHERAPEUTICUSE-Thisisaresearch-gradebiosimilar.ThischimericmouseantibodywasmadeusingthevariabledomainsequencesoftheoriginalHumanIgG4format,forimprovedcompatibilitywithexistingreagents,assaysandtechniques.
SpeciesandIsotype:MouseIgG1,FcSilent™,kappaCloneNumber:M200(Volociximab)
UniProtAccessionNumberofTargetProtein:P08648
AlternativeName(s)ofTarget:Fibronectinreceptor;CD49antigen-likefamilymemberE;Integrinalpha-F;VLA-5;CD49e.
PublishedApplication(s):ELISA;FC;IF;Block;IHC
PublishedSpeciesReactivity:Human
Immunogen:Heterodimerica5ß1Fcfusionprotein
Specificity:Theantibodybindstohumanα5β1 integrinwithaKdof0.367nM(determinedbyBiacore),anEC50of0.2nMandanIC50of2.3nM.
ApplicationNotes:Theantibodybindsspecificallytoα5β1 integrin,whichispartofthesuperfamilyofglycoproteintransmembranereceptorsforligandssuchasfibronectin,vitronectin,lamininsandcollagens.Theα5β1 integrinreceptorplaysakeyroleincellularprocessessuchasinflammation,cellproliferation,angiogenesisandtumourmetastasis.Comprisingthevariabledomainoftheoriginalmouseantibody,achimericmouse:humanIgG4versionofthisantibodyhasbeen testedinvivo:Incynomolgusmonkeyswithlaser-inducedchoroidalneovascularization(CNV),inrabbitmodelsandinhumanvolunteers.TheantibodyreachedPhaseIIclinicaltrialswithPDLBiopharmaandBiogen-Idec.
AntibodyFirstPublishedin:
Ramakrishnanetal.Preclinicalevaluationofananti-alpha5beta1integrin antibody asanovelanti-angiogenicagent.JExpTherOncol.2006;5(4):273-86.PMID:17024968Noteonpublication:Describestheroleofα5β1 integrinintheprogressionofangiogenesis,andthegenerationofVolociximab,achimericmonoclonalantibodywhoseinvitroandinvivouseisevaluatedfortherapeuticuse.
ProductForm
Purification:ProteinAaffinitypurifiedSuppliedin:PBSonly.
StorageRecommendation:Storeat4°Cforupto3months.Forlongertermstoragealiquotintosmallvolumesandstoreat-20°CConcentration:Seeviallabel.